National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Genvoya® is indicated for the treatment of adults and adolescents infected with human immunodeficiency virus – 1 (HIV-1).

Rapid Review

Commenced Completed Outcome
24/11/2015 05/01/2016 Full Pharmacoeconomic Evaluation Not Recommended